9
Participants
Start Date
August 6, 2023
Primary Completion Date
December 18, 2024
Study Completion Date
December 18, 2024
Ceftobiprole medocaril
Ceftobiprole medocaril: 7.5 mg/kg every 12 hours to 15 mg/kg every 8 hours, administered IV as a 2-hour infusion.
Pauls Stradins Clinical University Hospital, Riga
Children Clinical University Hospital - Neonatology Clinic, Riga
"Acibadem City Clinic University Hospital Tokuda EAD, Neonatology Department", Sofia
MHAT Dr. Stamen Iliev AD Montana, Neonatology Department, Montana
"UMHAT Sveti Georgi EAD, Pediatric surgery Clinic", Plovdiv
Tallinn Childrens' Hospital, Tallinn
West Virginia University, Morgantown
Lithuanian Health Science University Hospital Kauno klinikos - Neonatology Clinic, Kaunas
NorthShore University HealthSystem-Evanston Hospital, Evanston
Klinikum der Universität München, Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, Munich
Vilnius University Hospital Santaros klinikos - Neonatology Center, Vilnius
Ginekologiczno-Położniczy Szpital Kliniczny im. Marcinkowskiego, Poznan
Szpital Uniwersytecki - Klinika Neonatologii, Wroclaw
Univerzitna nemocnica Martin, Martin
Lead Sponsor
Basilea Pharmaceutica
INDUSTRY